IMR Press / EJGO / Volume 30 / Issue 5 / pii/2009131

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Small cell carcinoma of the uterine cervix: clinicopathologic study of 20 cases in a single center

Show Less
1 Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University, Kyung Hee Medical Center (Korea)
2 Department of Pathology,College of Medicine, University of Ulsan, Asan Medical Center, Seoul (Korea)
3 Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul (Korea)
Eur. J. Gynaecol. Oncol. 2009, 30(5), 539–542;
Published: 10 October 2009
Abstract

Purpose: To investigate clinicopathologic findings of patients with small cell carcinoma of the uterine cervix (SCCUC), and evaluate their prognosis. Methods: We retrospectively reviewed the medical records of 20 patients with histologically confirmed SCCUC treated between October 1996 and December 2004 at Asan Medical Center, Korea. The review included demographic data, pathologic findings, treatments, and outcomes. Results: Of 1,358 invasive cervical carcinoma, the incidence of SCCUC was 1.5%. Median age was 45.5 years. The clinical stages were I b in 11, IIa in two, IIb in one, IIIa in one, IIIb in one, IVa in three and IVb in one. Fourteen patients underwent radical hysterectomy. Ten patients are alive and nine show no evidence of disease. Median overall survival was 77.0 months and 5-year overall survival rate was 50%. There was significant difference in overall survival with FIGO stage and tumor mass size. Conclusion: Advanced FIGO stage and tumor mass size are poor prognostic factors for overall survival in patients with SCCUC. Even though SCCUC is a highly aggressive neoplasm, early diagnosis and combined therapeutic modalities may lead to longer survival in some patients.

Keywords
Small cell carcinoma
Uterine cervix
Prognostic factor
Survival
Treatment
Share
Back to top